CDK8-IN-14
CDK8-IN-14 (compound 12) inhibits CDK8 with an IC50 value of 39.2 nM and has anti-AML cell proliferation activity (molm-13 GC50 = 0.02±0.01μM, MV4-11 GC50 = 0.03±0.01μM) [1].
Product Specifications
CAS Number
[2924193-12-2]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk8-in-14.html
Solubility
10 mM in DMSO
Smiles
O=C(N)C1=CC=CC(C2=CN=C(NC=C3C4=COC=C4)C3=C2)=C1
Molecular Formula
C18H13N3O2
Molecular Weight
303.31
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6505218-01 0.1 mL
USP20, NT (Ubiquitin Carboxyl-terminal Hydrolase 20, Ubiquitin Thiolesterase 20, Ubiquitin-specific-processing Protease 20, Deubiquitinating Enzyme 20, VHL-interacting Deubiquitinating Enzyme 2, hVDU2, KIAA1003, LSFR3A, VDU2) (MaxLight 550)
Ask
View Details 
MBS6505218-02 5x 0.1 mL
USP20, NT (Ubiquitin Carboxyl-terminal Hydrolase 20, Ubiquitin Thiolesterase 20, Ubiquitin-specific-processing Protease 20, Deubiquitinating Enzyme 20, VHL-interacting Deubiquitinating Enzyme 2, hVDU2, KIAA1003, LSFR3A, VDU2) (MaxLight 550)
Ask
View Details 
